Mark Harvey, MD
Radiation Oncology · Orlando, FLNPI 1558380907
Payments from drug & device makers
Across 26 payments — averaging $80.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Telix Pharmaceuticals$858
- Novocure Inc.$302
- Medtronic$162
- GE HealthCare$139
- Johnson & Johnson$135
- GT Medical Technologies, Inc$125
- plus $384 from 7 others
What the payments were for
- Travel & lodging$36517%
- Food & beverage$1,73883%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Telix Pharmaceuticals | 5 | $858 |
| Novocure Inc. | 3 | $302 |
| Medtronic | 1 | $162 |
| GE HealthCare | 1 | $139 |
| Johnson & Johnson | 2 | $135 |
| GT Medical Technologies, Inc | 1 | $125 |
| Novartis | 4 | $107 |
| Teleflex LLC | 1 | $95 |
| Merck | 2 | $51 |
| Blue Earth Diagnostics | 2 | $49 |
| Bayer | 2 | $35 |
| Varian Medical Systems, Inc. | 1 | $27 |
| Tersera Therapeutics LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,104 in reported general payments places this provider in the 65th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride ErOxybutynin Chloride | 51 | $1,198 |
| SsdSilver Sulfadiazine | 38 | $1,184 |
| Tamsulosin Hcl | 99 | $1,065 |
| Sucralfate | 25 | $958 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $258 |
| Pantoprazole Sodium | 19 | $115 |
| Hydrocortisone | 11 | $98 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Orlando
- Shravan KandulaOrlando$477K
- Ravi ShridharOrlando$307K
- Patrick KellyOrlando$211K
- Akash NandaOrlando$165K
- Imran MohiuddinOrlando$149K
- Bridget KoontzOrlando$114K
- Charles HodgeOrlando$84K
- Naren RamakrishnaOrlando$77K
- Shane SteckleinOrlando$44K
- Justin RineerOrlando$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.